Hilde Windels
Chairman en CELYAD ONCOLOGY SA .
Fortuna: - $ al 31/03/2024
Perfil
Hilde Windels is the founder and currently holds the position of Chief Executive Officer & Director at Antelope.
Dx BV, a company founded in 2019.
She is also currently serving as the Executive Chairman & Co-Chief Executive Officer at MyCartis NV since 2011, Chairman at Celyad Oncology SA since 2018, and Independent Non-Executive Director at MDxHealth SA since 2017.
Ms. Windels is also a Director at Gimv NV, Microphyt SA, and Windels Hilde BV, which she founded in 2001.
Additionally, she is an Independent Director at PHAXIAM Therapeutics SA starting in 2023.
Ms. Windels has previously held the position of Co-Chief Executive Officer at Biocartis SA from 2015 to 2017.
She was also the Chief Financial Officer & Director at deVGen NV from 1999 to 2008.
Ms. Windels served as an Independent Director at Ablynx NV from 2017 to 2018 and as a Director at Vlaams Instituut voor Biotechnologie - Flanders Institute from 2013 to 2019.
She was an Executive Director at Biocartis Group NV from 2011 to 2019.
Ms. Windels has also held positions as a Manager at ING Bank NV, Amsterdam, succursale de Lancy and as the Chief Financial Officer at SEPS Pharma NV.
Ms. Windels obtained her graduate degree from Katholieke Universiteit Leuven in 1987.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/12/2022 | 0 ( -.--% ) | - $ | 31/03/2024 | |
MDXHEALTH S.A.
-.--% | 31/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Hilde Windels
| Empresas | Cargo | Inicio |
|---|---|---|
| MDXHEALTH SA | Director/Board Member | 01/11/2017 |
| CELYAD ONCOLOGY SA | Chairman | 23/06/2022 |
| GIMV NV | Director/Board Member | - |
| PHAXIAM THERAPEUTICS S.A. | Director/Board Member | 23/06/2023 |
MyCartis NV
 MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Chief Executive Officer | 01/01/2015 |
Antelope Dx BV
 Antelope Dx BV Packaged SoftwareTechnology Services Antelope Dx BV develops a point-of-need diagnostics platform that provides patients, consumers, and healthcare professionals with on-the-spot access to key health parameters. The private company is based in Ghent, Belgium. The Belgian company was founded in 2019 by Jan-Willem Hoste and Hilde Windels. Hilde Windels has been the CEO since 2019. | Founder | 01/01/2019 |
| Windels Hilde BV | Director/Board Member | 01/01/2001 |
Microphyt SA
 Microphyt SA BiotechnologyHealth Technology Microphyt SA researches, develops, produces and markets natural bioactive products from microalgae. Its solutions are intended to address the needs of personal-care, food and health-care industries worldwide, through a differentiated and sustainable approach and proprietary technologies allow controlled and industrial-scale supply of microalgae biomass and extracts. The firm''s Industrial scale photo bioreactors developed and patented and are designed to produce specific strains of microalgae by preserving cell integrity and yielding commercial quantities of slow-growing or biofilm-forming species. The company was founded by Arnaud Muller-Feuga in 2007 and is headquartered in Baillargues, France. | Director/Board Member | - |
Antiguos cargos conocidos de Hilde Windels.
| Empresas | Cargo | Fin |
|---|---|---|
Vlaams Instituut voor Biotechnologie - Flanders Institute
 Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | Director/Board Member | 01/06/2019 |
| ░░░░░░░░░ ░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Formación de Hilde Windels.
| Katholieke Universiteit Leuven | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| MDXHEALTH SA | Health Technology |
| GIMV NV | Finance |
| CELYAD ONCOLOGY SA | Health Technology |
| BIOCARTIS GROUP NV | Health Technology |
| Empresas privadas | 12 |
|---|---|
ING Bank NV, Amsterdam, succursale de Lancy/Genève
 ING Bank NV, Amsterdam, succursale de Lancy/Genève Regional BanksFinance ING Bank NV, Amsterdam, succursale de Lancy/Genève provides commercial banking services. Its banking products include saving and current accounts, credit cards, loans and investments. The firm offers vehicle insurance, home insurance, life insurance and retirement plans. The company was founded in 1871 and is headquartered in Brussels, Belgium. | Finance |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
MyCartis NV
MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Health Technology |
ERYTech Pharma SA
 ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Health Technology |
SEPS Pharma NV
 SEPS Pharma NV Pharmaceuticals: GenericHealth Technology SEPS Pharma NV provides controlled drug delivery and develops self emulsifying pro drug systems. Its services include preformulation, formulation development and analytical development. The company was founded on October 19, 2007 and is headquartered in Diepenbeek, Belgium. | Health Technology |
FlandersBio vzw
 FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Commercial Services |
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Health Technology |
Microphyt SA
Microphyt SA BiotechnologyHealth Technology Microphyt SA researches, develops, produces and markets natural bioactive products from microalgae. Its solutions are intended to address the needs of personal-care, food and health-care industries worldwide, through a differentiated and sustainable approach and proprietary technologies allow controlled and industrial-scale supply of microalgae biomass and extracts. The firm''s Industrial scale photo bioreactors developed and patented and are designed to produce specific strains of microalgae by preserving cell integrity and yielding commercial quantities of slow-growing or biofilm-forming species. The company was founded by Arnaud Muller-Feuga in 2007 and is headquartered in Baillargues, France. | Health Technology |
| Windels Hilde BV | |
Antelope Dx BV
Antelope Dx BV Packaged SoftwareTechnology Services Antelope Dx BV develops a point-of-need diagnostics platform that provides patients, consumers, and healthcare professionals with on-the-spot access to key health parameters. The private company is based in Ghent, Belgium. The Belgian company was founded in 2019 by Jan-Willem Hoste and Hilde Windels. Hilde Windels has been the CEO since 2019. | Technology Services |
| PHAXIAM Therapeutics SA |
- Bolsa de valores
- Insiders
- Hilde Windels
